{"transactions":[{"id":830413,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:21:33.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":574385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027."}],"balance_after":574385,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":574385},"source":{"system":"sec-edgar","filing":"0001104659-26-033957","document":"tm269618-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033957/tm269618-3_4seq1.xml","form_type":"4"}},{"id":1379771,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:46:22.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-112756","document":"tm2427081-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112756/tm2427081-3_4seq1.xml","form_type":"4"}},{"id":1686704,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:02:30.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024."}],"balance_after":800000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-001952","document":"tm242134-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001952/tm242134-3_4seq1.xml","form_type":"4"}},{"id":2163783,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:49:01.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":185333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":185333,"derivative":{"exercise_price":0.5,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":185333},"source":{"system":"sec-edgar","filing":"0001104659-22-098629","document":"tm2225305-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098629/tm2225305-2_4seq1.xml","form_type":"4"}}]}